【持续性肾脏替代治疗CRRT英文ppt课件】Acute Renal Failure (106p).ppt

【持续性肾脏替代治疗CRRT英文ppt课件】Acute Renal Failure (106p).ppt

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
【持续性肾脏替代治疗CRRT英文ppt课件】Acute Renal Failure (106p)

Acute Renal Failure;Abbreviations;Key Concepts;Key Concepts;Acute Renal Failure: Definition;Acute Renal Failure: Definition; ESRD, end-stage renal disease? GFR, glomerular filtration rate Scr, serum creatinine;ARF Epidemiology ;Incidence and Outcomes of Acute Renal Failure Relative to Where It Occurs;Etiology;11;Etiology;Pathophysiology;Pseudorenal and Functional ARF;Prerenal Acute Renal Failure;Intrinsic Acute Renal Failure;Postrenal Acute Renal Failure;Diagnosis;Patient Assessment;Patient Assessment;Patient Assessment;Signs and Symptoms; Laboratory Tests;Other Diagnostic Tests;Clinical Presentation;Laboratory Test Interpretation;Glomerular filtration rate?(GFR; mL/min) and serum creatinine (Scr; g/dL) versus time following acute renal injury. Prior to time 0, a GFR of 120 mL/min and a Scr?of 1.0 g/dL exist. At time 0, an abrupt renal artery?thrombus?forms, depriving one kidney of renal blood flow. Composite GFR immediately declines by 50% to approximately 60 mL/min. However, Scr?does not increase immediately, as it is dependent on creatinine production and attainment of steady-state serum concentrations.;Laboratory Test Interpretation;Laboratory Test Interpretation;Laboratory Test Interpretation;Laboratory Test Interpretation;Laboratory Test Interpretation;Differentiating ARF Causes;Urine Analysis as Guide to ARF Etiology; Differential Diagnosis of ARF on Basis of Urine Microscopic Examination Findings;Novel Biomarkers ;Diagnostic Procedures;Prevention of ARF;Desired Outcome;Desired Outcome; Prevention;Prevention of AKI;Nonpharmacologic Therapies ; Nonpharmacologic Therapies;Pharmacologic Therapies;Loop Diuretics;Clinical Controversy;Dopamine Agonists;Clinical Controversy;Antioxidants;Antioxidants;Other Agents;Other Agents;Glycemic Control;Treatment for ARF;Treatment; Nonpharmacologic; Nonpharmacologic; Nonpharmacologic; Nonpharmacologic;Indications for Renal Replacement Therapy (AEIOUs);Renal Replacement Therapies;Intermittent Hemodialysis (IHD); Continuous Renal

文档评论(0)

2017meng + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档